Clinical Trial: Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK +

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

Official Title: Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK +

Brief Summary: To study the correlation between the polymorphism of the main immunity genes and progression-free survival in ALCL of the child.

Detailed Summary:
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Current Primary Outcome: Number of single nucleotide polymorphisms in main immunogenicity genes using VERACODE ILLUMINA technology [ Time Frame: up to 78 months ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Gustave Roussy, Cancer Campus, Grand Paris

Dates:
Date Received: September 7, 2016
Date Started: April 2010
Date Completion: October 2017
Last Updated: January 25, 2017
Last Verified: January 2017